RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+9.18%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.19B
AUM Growth
+$4.19B
Cap. Flow
+$31.2M
Cap. Flow %
0.75%
Top 10 Hldgs %
34.6%
Holding
124
New
3
Increased
47
Reduced
8
Closed
3

Top Buys

1
MLYS icon
Mineralys Therapeutics
MLYS
$18.3M
2
BMEA icon
Biomea Fusion
BMEA
$17.6M
3
RVMD icon
Revolution Medicines
RVMD
$15.2M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$14.5M
5
PLRX icon
Pliant Therapeutics
PLRX
$13.1M

Top Sells

1
BAX icon
Baxter International
BAX
$58.6M
2
PEN icon
Penumbra
PEN
$20.8M
3
ALGN icon
Align Technology
ALGN
$18.4M
4
IMCR icon
Immunocore
IMCR
$15.8M
5
CINC
CinCor Pharma, Inc. Common Stock
CINC
$13.7M

Sector Composition

1 Healthcare 97.18%
2 Consumer Staples 1.05%
3 Industrials 0.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FULC icon
101
Fulcrum Therapeutics
FULC
$351M
$2.07M 0.05% 727,673 +343,083 +89% +$978K
TPST icon
102
Tempest Therapeutics
TPST
$44M
$1.91M 0.05% 823,654 – –
GMDA
103
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$1.9M 0.05% 2,344,649 -1,775,234 -43% -$1.44M
LPTX icon
104
Leap Therapeutics
LPTX
$12M
$1.58M 0.04% 4,655,186 +995,339 +27% +$338K
EPIX icon
105
ESSA Pharma
EPIX
$11.4M
$1.56M 0.04% 524,944 – –
NKTX icon
106
Nkarta
NKTX
$151M
$1.4M 0.03% 393,389 – –
GOSS icon
107
Gossamer Bio
GOSS
$562M
$1.39M 0.03% 1,100,274 +724,226 +193% +$913K
SYRE icon
108
Spyre Therapeutics
SYRE
$996M
$990K 0.02% 3,413,906 – –
SPRO icon
109
Spero Therapeutics
SPRO
$116M
$971K 0.02% 669,533 – –
ALT icon
110
Altimmune
ALT
$338M
$942K 0.02% 223,255 – –
VINC
111
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$927K 0.02% 891,719 – –
CGEN icon
112
Compugen
CGEN
$132M
$906K 0.02% 1,289,990 – –
APLT icon
113
Applied Therapeutics
APLT
$71M
$633K 0.02% 780,791 +184,111 +31% +$149K
BCEL
114
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$413K 0.01% 362,530 – –
TLPH icon
115
Talphera
TLPH
$11.1M
$208K 0.01% 316,460 – –
NUVB.WS icon
116
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$16.1K ﹤0.01% 134,028 – –
BAX icon
117
Baxter International
BAX
$12.7B
– – -1,150,000 Closed -$58.6M
ETNB icon
118
89bio
ETNB
$1.34B
– – 0 – –
FSTX
119
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– – -751,889 Closed -$4.75M
CINC
120
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– – -1,116,578 Closed -$13.7M
1 2 3 4
5